Patent Notice

Last Updated: February 18, 2026

1. Patent Pending Status

Certain technology described herein is the subject of a pending patent application filed with the Canadian Intellectual Property Office (CIPO):

• Application Number: 3,302,135
• Filing Date: February 18, 2026
• Title: Containerized Clinical Data Management System with Network Isolation and Modular Inference

This patent application is currently pending. The patent-pending designation indicates that formal patent protection has been sought for the described technology.

2. Technology Overview

The patent application covers a range of innovations related to clinical data management and secure software deployment, including but not limited to:

• Containerized clinical data management with network-isolated architecture designed for secure operation within healthcare environments;
• Cryptographic licensing mechanisms enabling secure offline activation and operation without persistent connectivity requirements;
• Non-destructive medical image rendering with real-time state persistence through persistent network connections;
• Modular local computational analysis that performs data processing and inference entirely within the local deployment, without external data transmission; and
• Atomic software update procedures with integrity verification to ensure reliable, uninterrupted operation during version transitions.

The foregoing descriptions are provided for general informational purposes and do not represent the full scope of the claims contained in the patent application.

3. Intellectual Property Rights

The technology, architecture, and methods embodied in Dermi products are protected by intellectual property rights, including pending patent applications, trade secrets, and copyright. Unauthorized reproduction, reverse engineering, derivation of source code, or unauthorized use of the protected technology may constitute infringement of applicable intellectual property laws. All rights not expressly granted are reserved.

4. Notice to Third Parties

The patent-pending designation described in this notice applies to technology incorporated within Dermi products. The filing of the patent application establishes a documented priority date and constitutes prior art with respect to the described inventions.

Dermi reserves the right to enforce its intellectual property rights to the fullest extent permitted by applicable law, including seeking injunctive relief and damages for any unauthorized use, reproduction, or misappropriation of the protected technology.

Parties interested in licensing inquiries, prior art discussions, or other intellectual property matters are invited to contact legal@dermi.ai.

5. No Warranty of Completeness

This notice does not constitute a comprehensive disclosure of all intellectual property rights held or pursued in connection with Dermi products. Additional patents, patent applications, trade secrets, copyrights, or other intellectual property rights may apply. The absence of a specific reference to any particular intellectual property right in this notice shall not be construed as a waiver or relinquishment of such right.

6. Governing Law

This notice and any disputes arising from or relating to the intellectual property described herein shall be governed by and construed in accordance with the laws of the Province of Ontario and the federal laws of Canada applicable therein, without regard to conflict of law principles. The courts located in Toronto, Ontario shall have exclusive jurisdiction over any proceedings related to this notice.

Contact

Dermi Inc.
18 King Street East, Suite 1400
Toronto, ON M5C 1C4
Canada

Legal Inquiries: legal@dermi.ai
General Inquiries: support@dermi.ai